颅内血管介入治疗缺血性脑血管病的临床疗效及预后分析(1)
[摘要] 目的 缺血性腦血管病患者通过颅内血管介入治疗，对患者的临床疗效以及预后情况进行研究分析。方法 对该院在2017年1月—2018年1月期间内收治的患者随机抽取出56例缺血性脑血管病患者当成该次研究的研究目标，根据患者的治疗方法的不同将小组进行划分，分为观察组(n=28)和对照组(n=28)。观察组患者通过颅内血管介入治疗，对照组患者则通过常规的药物进行治疗，对两组患者的治疗前后的血管收缩期峰流速(Vs)以及舒张末期流速(Vd)进行比较，对两组患者的脑梗塞、短暂性脑缺血发作概率以及病死概率进行比较，从而评价颅内血管介入治疗的临床效果以及预后情况。结果 两组患者治疗前的Vs以及Vd值较高，之间比较差异无统计学意义(P>0.05)，治疗后，观察组患者的Vs为(100.6±30.6)，Vd为(21.3±10.5)，对照组患者的Vs为(141.9±27.9)，Vd为(39.1±11.9)，两组患者的Vs以及Vd均下降，但是观察组下降幅度更大，组间差异有统计学意义(t=5.843、5.220，P<0.05);观察组患者的脑梗塞、短暂性脑缺血发作概率以及病死概率分别为：3.6%(1/28)、3.6%(1/28)、10.7%(3/28)，对照组患者的脑梗塞、短暂性脑缺血发作概率以及病死概率分别为：21.4%(6/28)、21.4%(6/28)、28.6%(8/28)，组间差异有统计学意义(P<0.05)。结论 缺血性脑血管病患者通过颅内血管介入治疗，可以得到显著的治疗效果，预后情况优良。
[关键词] 颅内血管介入治疗;缺血性脑血管病;临床疗效;预后情况
[Abstract] Objective To study the clinical efficacy and prognosis of patients with ischemic cerebrovascular disease through intracranial vascular interventional therapy. Methods From January 2017 to January 2018， 56 patients with ischemic cerebrovascular disease were randomly selected from this hospital and they were taken as the research target of this study. According to the treatment methods， the patients were divided into two groups， which were divided into observation group (n=28) and control group (n=28). Patients in the observation group were treated with intracranial vascular intervention， and patients in the control group were treated with conventional drugs. The peak vasomotor velocity (Vs) and end-diastolic velocity (Vd) of the two groups were compared before and after treatment. The patients' cerebral infarction， transient ischemic attack probability and mortality were compared to evaluate the clinical effect and prognosis of intracranial vascular interventional therapy. Results The values of Vs and Vd before treatment were higher in the two groups， and there difference was no statistically significant between them(P>0.05). After treatment，the Vs in the observation group was (100.6 ± 30.6) and Vd was (21.3±10.5). The Vs of the control group was (141.9±27.9) and the Vd was (39.1±11.9). The Vs and Vd of the two groups of patients decreased， but the observation group had a larger decline， and the differences was statistically significantly(t=5.843，5.220，P<0.05); the probability of cerebral infarction， transient ischemic attack， and mortality in the observation group were： 3.6%(1/28)，3.6%(1/28)，10.7%(3/28)， the probability of cerebral infarction， transient ischemic attack and mortality in the control group were 21.4%(6/28)，21.4%(6/28)，28.6%(8/28)，and the difference was statistically significant(P<0.05). Conclusion Patients with ischemic cerebrovascular disease can obtain significant therapeutic effects through intracranial vascular interventional therapy， and the prognosis is excellent， which is worthy of popularization and application in clinic., 百拇医药(周海云)
[关键词] 颅内血管介入治疗;缺血性脑血管病;临床疗效;预后情况
[Abstract] Objective To study the clinical efficacy and prognosis of patients with ischemic cerebrovascular disease through intracranial vascular interventional therapy. Methods From January 2017 to January 2018， 56 patients with ischemic cerebrovascular disease were randomly selected from this hospital and they were taken as the research target of this study. According to the treatment methods， the patients were divided into two groups， which were divided into observation group (n=28) and control group (n=28). Patients in the observation group were treated with intracranial vascular intervention， and patients in the control group were treated with conventional drugs. The peak vasomotor velocity (Vs) and end-diastolic velocity (Vd) of the two groups were compared before and after treatment. The patients' cerebral infarction， transient ischemic attack probability and mortality were compared to evaluate the clinical effect and prognosis of intracranial vascular interventional therapy. Results The values of Vs and Vd before treatment were higher in the two groups， and there difference was no statistically significant between them(P>0.05). After treatment，the Vs in the observation group was (100.6 ± 30.6) and Vd was (21.3±10.5). The Vs of the control group was (141.9±27.9) and the Vd was (39.1±11.9). The Vs and Vd of the two groups of patients decreased， but the observation group had a larger decline， and the differences was statistically significantly(t=5.843，5.220，P<0.05); the probability of cerebral infarction， transient ischemic attack， and mortality in the observation group were： 3.6%(1/28)，3.6%(1/28)，10.7%(3/28)， the probability of cerebral infarction， transient ischemic attack and mortality in the control group were 21.4%(6/28)，21.4%(6/28)，28.6%(8/28)，and the difference was statistically significant(P<0.05). Conclusion Patients with ischemic cerebrovascular disease can obtain significant therapeutic effects through intracranial vascular interventional therapy， and the prognosis is excellent， which is worthy of popularization and application in clinic., 百拇医药(周海云)
参见：首页 > 医疗版 > 疾病专题 > 神经内科 > 脑血管病